Ropeginterferon alfa-2b every 2 weeks as a novel pegylated interferon for patients with chronic hepatitis B

BACKGROUND: Ropeginterferon alfa-2b is a novel mono-pegylated interferon that has only one major form as opposed to 8–14 isomers of other on-market pegylated interferon, allowing injection every two or more weeks with higher tolerability. It received European Medicines Agency and Taiwan marketing au...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Yi-Wen, Hsu, Chao-Wei, Lu, Sheng-Nan, Yu, Ming-Lung, Su, Chien-Wei, Su, Wei-Wen, Chien, Rong-Nan, Hsu, Ching-Sheng, Hsu, Shih-Jer, Lai, Hsueh-Chou, Qin, Albert, Tseng, Kuan-Chiao, Chen, Pei-Jer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer India 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7803873/
https://www.ncbi.nlm.nih.gov/pubmed/33099752
http://dx.doi.org/10.1007/s12072-020-10098-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7803873/
https://www.ncbi.nlm.nih.gov/pubmed/33099752
http://dx.doi.org/10.1007/s12072-020-10098-y

Ejemplares similares